Last reviewed · How we verify
CM383
At a glance
| Generic name | CM383 |
|---|---|
| Sponsor | Keymed Biosciences Co.Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of CM383 in Healthy Subjects (PHASE1)
- A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease (PHASE1)
- Single Dose Escalation Study of CM383 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |